Fundz

Molecular Templates, Inc. reported raising $15 Million in an initial SEC Form D filing, from an offering of $15 Million

PRIVATENov 27, 2019

Amount Raised

$15 Million

$15 Million sold, per SEC Form D (first sale Nov 27, 2019)

Round Type

Venture

AustinBiotechnology

Quick answer

Molecular Templates raised $15 Million in a funding round, dated November 27, 2019. Molecular Templates is based in Austin, Texas, United States.

How much did Molecular Templates raise?
Molecular Templates raised $15 Million in a funding round on November 27, 2019.
What does Molecular Templates do?
Molecular Templates, Inc. (MTEM) is a clinical stage biopharmaceutical company focused on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases.
Where is Molecular Templates based and how big is it?
Molecular Templates is based in Austin, Texas, United States.
Who are the decision-makers at Molecular Templates?
Fundz holds 1 contact at Molecular Templates. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Molecular Templates that raised within 45 days of this round, from Fundz verified event records.

  • Prelude raised $10M on January 10, 2020.
  • Pliant Therapeutics raised $48M on January 9, 2020.
  • ORTHALIGN INC raised $3.2M (Seed) on January 9, 2020.
  • Jade Biosciences raised $2.5M (Seed) on January 8, 2020.
  • Microbot Medical raised an undisclosed amount on January 7, 2020.
  • Aegle Therapeutics raised $4M (Seed) on January 7, 2020.

Who to call at Molecular Templates, and when

A new round usually means Molecular Templates is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Molecular Templates raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Molecular Templates, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Molecular Templates. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Molecular Templates

Location

9301 Amberglen Blvd

Austin, Texas, United States

About

Molecular Templates, Inc. (MTEM) is a clinical stage biopharmaceutical company focused on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform with unique mechanisms of actions which are highly differentiated from antibody drug conjugates (ADCs). MTEM is developing MT-6402, which is in a Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients; MT-5111, which is in a Phase I clinical trial for the treatment of HER2-positive cancers; and MT-0169, which is in a Phase I clinical trial to treat relapsed/refractory myeloma. MTEM’s pipeline of ETBs in development for other targets include CTLA-4, TIGIT, TROP2, and BCMA. MTEM has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas. It also has an office in New York, NY.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Molecular Templates raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts38 people are listed at Molecular Templates. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Molecular Templates's next move

See what Strategic adds

Molecular Templates raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.